Skip to content

Mark Strobeck, President and CEO at Rockwell Medical, sold RMTI on Oct 1, 2026

Data as of Oct 16

▼ SELL$8.4K1,000 shares at $8.42Mark Strobeck President and CEORMTI Rockwell Medical, Inc.
Watch RMTI
Traded
Oct 1, 2026
Disclosed
Oct 5, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Mark Strobeck, President and CEO at Rockwell Medical, sold RMTI on Oct 1, 2026TRADEDDISCLOSED
RMTISimilar stocks (S&P 500 (SPY)), rebased to RMTI's price on the disclosure day
RMTI since disclosure
−9.7%
after the sale
Similar stocks (SPY) since disclosure
−1.5%
S&P 500 (SPY)

Change in closing price from Oct 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on RMTI →